Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension

• Main Authors: K. Stefanantoni (Author), I. Sciarra (Author), M. Vasile (Author), R. Badagliacca (Author), R. Poscia (Author), M. Pendolino (Author), C. Alessandri (Author), C.D. Vizza (Author), G. Valesini (Author), V. Riccieri (Author)
• Format: Book
• Published: PAGEPress Publications, 2015-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary arterial hypertension (PAH) can be idiopathic or secondary to autoimmune diseases, and it represents one of the most threatening complications of systemic sclerosis (SSc). Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with proinflammatory functions that appears to...